Education
About Us
Working with TipRanks
Follow Us
ClearPoint Neuro (CLPT)
NASDAQ:CLPT
Total Valuation
ClearPoint Neuro has a market cap or net worth of $296.50M. The enterprise value is $331.32M.
Market Cap$296.50M
Enterprise Value$331.32M
Share Statistics
ClearPoint Neuro has 28,427,418 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,427,418
Owned by Insiders10.72%
Owned by Institutions7.22%
Financial Efficiency
ClearPoint Neuro’s return on equity (ROE) is -0.74 and return on invested capital (ROIC) is -67.18%.
Return on Equity (ROE)-0.74
Return on Assets (ROA)-0.48
Return on Invested Capital (ROIC)-67.18%
Return on Capital Employed (ROCE)-0.68
Revenue Per Employee272.96K
Profits Per Employee-164.47K
Employee Count115
Asset Turnover0.80
Inventory Turnover1.79
Valuation Ratios
The current PE Ratio of ClearPoint Neuro is ―. ClearPoint Neuro’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value16.37
Price to FCF―
Price to Operating Cash Flow-30.17
PEG Ratio―
Income Statement
In the last 12 months, ClearPoint Neuro had revenue of 31.39M and earned -18.91M in profits. Earnings per share was -0.70.
Revenue31.39M
Gross Profit19.12M
Operating Income-19.75M
Pretax Income-18.91M
Net Income-18.91M
EBITDA-17.84M
Earnings Per Share (EPS)-0.70
Cash Flow
In the last 12 months, operating cash flow was -11.17M and capital expenditures -549.00K, giving a free cash flow of -11.71M billion.
Operating Cash Flow-11.17M
Free Cash Flow-11.71M
Free Cash Flow per Share-0.41
Dividends & Yields
ClearPoint Neuro pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.61
52-Week Price Change-6.81%
50-Day Moving Average11.08
200-Day Moving Average13.30
Relative Strength Index (RSI)53.96
Average Volume (3m)358.31K
Important Dates
ClearPoint Neuro upcoming earnings date is Nov 11, 2025, After Close (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend Date―
Financial Position
ClearPoint Neuro as a current ratio of 3.22, with Debt / Equity ratio of 33.49%
Current Ratio3.22
Quick Ratio2.56
Debt to Market Cap<0.01
Net Debt to EBITDA0.93
Interest Coverage Ratio0.00
Taxes
In the past 12 months, ClearPoint Neuro has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
ClearPoint Neuro EV to EBITDA ratio is -22.37, with an EV/FCF ratio of -43.27.
EV to Sales12.72
EV to EBITDA-22.37
EV to Free Cash Flow-43.27
EV to Operating Cash Flow-44.60
Balance Sheet
ClearPoint Neuro has $41.54M in cash and marketable securities with $6.61M in debt, giving a net cash position of -$34.93M billion.
Cash & Marketable Securities$41.54M
Total Debt$6.61M
Net Cash-$34.93M
Net Cash Per Share-$1.23
Tangible Book Value Per Share$0.92
Margins
Gross margin is 60.42%, with operating margin of -62.91%, and net profit margin of -60.25%.
Gross Margin60.42%
Operating Margin-62.91%
Pretax Margin-60.25%
Net Profit Margin-60.25%
EBITDA Margin-56.84%
EBIT Margin-62.91%
Analyst Forecast
The average price target for ClearPoint Neuro is $20.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$20.75
Price Target Upside87.27% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast19.68%
EPS Growth Forecast-13.17%